Biologic and Technology-Driven Treatments

Modern shoulder care is moving beyond simply treating pain. Newer biologic and technology-driven treatments aim to improve diagnosis, personalize treatment, support healing, and optimize recovery.

Dr. Streit’s approach combines evidence-based orthopaedic surgery, biologic treatment concepts, advanced imaging, and technology-guided planning.

Orthobiologics

Orthobiologics are treatments that use biologic substances to support healing, reduce inflammation, or improve the environment around injured tissue. Examples include platelet-rich plasma, bone marrow aspirate concentrate, growth-factor-based treatments, and other regenerative approaches.

The field is advancing quickly, but the evidence is not equal across all treatments. PRP has the strongest clinical foundation among commonly used orthobiologics, while many cell-based, exosome, and peptide-based products remain investigational for most orthopaedic uses. :contentReference[oaicite:3]{index=3}

Technology-guided diagnosis

Accurate diagnosis is the foundation of successful treatment. Advanced imaging, careful physical examination, diagnostic injections, and review of prior imaging or operative reports can help identify the true source of shoulder pain.

For complex shoulder problems, technology can help clarify:

• Rotator cuff tear size and muscle quality
• Shoulder arthritis severity
• Bone loss and deformity
• Implant position after prior surgery
• Whether symptoms are coming from the shoulder, neck, or another source

Advanced surgical planning

In shoulder replacement and revision surgery, modern planning tools can help evaluate bone anatomy, implant options, deformity correction, and surgical strategy before entering the operating room.

This is especially important for complex cases involving arthritis, bone loss, prior implants, fractures, or failed prior surgery.

Technology does not replace surgical judgment. It supports better decision-making and helps align the surgical plan with the patient’s anatomy and goals.

Regenerative medicine: promise and caution

Regenerative medicine has significant potential, but it is important to separate evidence-based treatment from marketing claims.

Some biologic therapies have meaningful data for specific indications. Others remain experimental, with uncertain dosing, product composition, safety, and long-term outcomes.

The AAOS notes that PRP is used for selected tendon conditions, early arthritis, and as an aid to healing after certain tendon repairs, but stem cell therapies require careful patient education because benefit depends on the condition, product, and available evidence. :contentReference[oaicite:4]{index=4}

Safety and regulatory considerations

Patients should be cautious about clinics making guaranteed claims about stem cells, exosomes, or “regenerative” products. Many marketed biologic treatments are not FDA-approved for orthopaedic healing, and product quality can vary.

Any biologic or technology-driven treatment should be discussed with a qualified physician who can explain the evidence, risks, alternatives, cost, and realistic expectations.

What this means for patients

The future of shoulder care will continue to involve more precise diagnosis, better imaging, improved implants, biologic support, and individualized rehabilitation.

The most important principle remains simple: advanced treatments should be used only when they improve decision-making, safety, healing potential, or patient outcomes.

Technology and biologics are powerful tools—but the best results still come from accurate diagnosis, appropriate indications, meticulous technique, and a treatment plan built around the individual patient.